Iliac artery endofibrosis: diagnostic dilemna and treatment options
CONCLUSION: Correct diagnosis is essential in the treatment of EIAE. A complete and multidisciplinary pathway should be followed to distinguish vascular from non-vascular causes. Correct lesion localization is crucial and besides CTA or MRA, more sophisticated techniques such as dynamic angiography or intravascular ultrasound might be needed.PMID:38693887 | DOI:10.1080/00015458.2024.2348234 (Source: Acta Chirurgica Belgica)
Source: Acta Chirurgica Belgica - May 2, 2024 Category: Surgery Authors: K VanLangenhove Uijtterhaegen G Moreels N Randon C Vermassen F Source Type: research
Chronic Total Occlusion Percutaneous Coronary Intervention: Mindset, Culture, and Continuous Improvement
The development of complex and higher risk indicated procedures (CHIP) and chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has brought along new challenges in terms of operator training. While the technical aspect of learning CHIP/CTO PCI have been described in detail, very little has been discussed on the mental skills that the operator must possess or develop to be successful.Moreover, an at least equally important piece to CHIP/CTO PCI program development is the professional culture of the institution where these complex procedures are performed, as this can mark the difference between a thriving ...
Source: The American Journal of Cardiology - May 2, 2024 Category: Cardiology Authors: Lorenzo Azzalini, William L. Lombardi Source Type: research
Back-up type guiding catheter for percutaneous coronary intervention after transcatheter aortic valve replacement with a self-expandable valve
(Source: Cardiovascular Intervention and Therapeutics)
Source: Cardiovascular Intervention and Therapeutics - May 2, 2024 Category: Cardiology Source Type: research
Ranolazine in chronic total occlusion percutaneous coronary intervention
We examined 11 491 chronic total occlusion (CTO) percutaneous coronary interventions (PCI) that were performed at 41 US and non-US centers between 2012 and 2023 in the PROGRESS-CTO Registry. Patients on ranolazine at baseline had more comorbidities, more complex lesions, lower procedural and technical success (based on univariable but not multivariable analysis), and higher incidence of major adverse cardiac events (MACE) (on both univariable and multivariable analysis).PMID:38691399 | DOI:10.25270/jic/24.00059 (Source: The Journal of Invasive Cardiology)
Source: The Journal of Invasive Cardiology - May 1, 2024 Category: Cardiology Authors: Michaella Alexandrou Deniz Mutlu Athanasios Rempakos Ahmed Al Ogaili James W Choi Paul Poommipanit Khaldoon Alaswad Mir Babar Basir Rhian Davies Farouc A Jaffer Phil Dattilo Lorenzo Azzalini Nazif Aygul Niranjan Reddy Brian K Jefferson Sevket Gorgulu Jaik Source Type: research
Challenging situation of coronary artery anomaly associated with ischemia and/or risk of sudden death
World J Cardiol. 2024 Apr 26;16(4):173-176. doi: 10.4330/wjc.v16.i4.173.ABSTRACTCoronary artery anomaly is known as one of the causes of angina pectoris and sudden death and is an important clinical entity that cannot be overlooked. The incidence of coronary artery anomalies is as low as 1%-2% of the general population, even when the various types are combined. Coronary anomalies are practically challenging when the left and right coronary ostium are not found around their normal positions during coronary angiography with a catheter. If there is atherosclerotic stenosis of the coronary artery with an anomaly and percutaneo...
Source: Atherosclerosis - May 1, 2024 Category: Cardiology Authors: Shigenori Ito Source Type: research
Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway
Cardiovasc Toxicol. 2024 May 1. doi: 10.1007/s12012-024-09863-4. Online ahead of print.ABSTRACTVascular lesions frequently arise as complication in patients diagnosed with diabetes mellitus (DM). Presently, percutaneous coronary intervention (PCI) and antithrombotic therapy serve as primary treatments. However, in-stent restenosis persists as a challenging clinical issue following PCI, lacking sustained and effective treatment. Linarin (LN) exhibits diverse pharmacological activities and is regarded as a potential drug for treating various diseases, including DM. But its specific role in restenosis after vascular injury in...
Source: Cardiovascular Toxicology - May 1, 2024 Category: Cardiology Authors: Aihua Jiang Lin Liu Jianping Wang Yinglan Liu Shanshan Deng Tao Jiang Source Type: research
Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway
Cardiovasc Toxicol. 2024 May 1. doi: 10.1007/s12012-024-09863-4. Online ahead of print.ABSTRACTVascular lesions frequently arise as complication in patients diagnosed with diabetes mellitus (DM). Presently, percutaneous coronary intervention (PCI) and antithrombotic therapy serve as primary treatments. However, in-stent restenosis persists as a challenging clinical issue following PCI, lacking sustained and effective treatment. Linarin (LN) exhibits diverse pharmacological activities and is regarded as a potential drug for treating various diseases, including DM. But its specific role in restenosis after vascular injury in...
Source: Cardiovascular Toxicology - May 1, 2024 Category: Cardiology Authors: Aihua Jiang Lin Liu Jianping Wang Yinglan Liu Shanshan Deng Tao Jiang Source Type: research
Challenging situation of coronary artery anomaly associated with ischemia and/or risk of sudden death
World J Cardiol. 2024 Apr 26;16(4):173-176. doi: 10.4330/wjc.v16.i4.173.ABSTRACTCoronary artery anomaly is known as one of the causes of angina pectoris and sudden death and is an important clinical entity that cannot be overlooked. The incidence of coronary artery anomalies is as low as 1%-2% of the general population, even when the various types are combined. Coronary anomalies are practically challenging when the left and right coronary ostium are not found around their normal positions during coronary angiography with a catheter. If there is atherosclerotic stenosis of the coronary artery with an anomaly and percutaneo...
Source: World Journal of Cardiology - May 1, 2024 Category: Cardiology Authors: Shigenori Ito Source Type: research
Challenging situation of coronary artery anomaly associated with ischemia and/or risk of sudden death
World J Cardiol. 2024 Apr 26;16(4):173-176. doi: 10.4330/wjc.v16.i4.173.ABSTRACTCoronary artery anomaly is known as one of the causes of angina pectoris and sudden death and is an important clinical entity that cannot be overlooked. The incidence of coronary artery anomalies is as low as 1%-2% of the general population, even when the various types are combined. Coronary anomalies are practically challenging when the left and right coronary ostium are not found around their normal positions during coronary angiography with a catheter. If there is atherosclerotic stenosis of the coronary artery with an anomaly and percutaneo...
Source: World Journal of Cardiology - May 1, 2024 Category: Cardiology Authors: Shigenori Ito Source Type: research
Challenging situation of coronary artery anomaly associated with ischemia and/or risk of sudden death
World J Cardiol. 2024 Apr 26;16(4):173-176. doi: 10.4330/wjc.v16.i4.173.ABSTRACTCoronary artery anomaly is known as one of the causes of angina pectoris and sudden death and is an important clinical entity that cannot be overlooked. The incidence of coronary artery anomalies is as low as 1%-2% of the general population, even when the various types are combined. Coronary anomalies are practically challenging when the left and right coronary ostium are not found around their normal positions during coronary angiography with a catheter. If there is atherosclerotic stenosis of the coronary artery with an anomaly and percutaneo...
Source: World Journal of Cardiology - May 1, 2024 Category: Cardiology Authors: Shigenori Ito Source Type: research
Ranolazine in chronic total occlusion percutaneous coronary intervention
We examined 11 491 chronic total occlusion (CTO) percutaneous coronary interventions (PCI) that were performed at 41 US and non-US centers between 2012 and 2023 in the PROGRESS-CTO Registry. Patients on ranolazine at baseline had more comorbidities, more complex lesions, lower procedural and technical success (based on univariable but not multivariable analysis), and higher incidence of major adverse cardiac events (MACE) (on both univariable and multivariable analysis).PMID:38691399 | DOI:10.25270/jic/24.00059 (Source: The Journal of Invasive Cardiology)
Source: The Journal of Invasive Cardiology - May 1, 2024 Category: Cardiology Authors: Michaella Alexandrou Deniz Mutlu Athanasios Rempakos Ahmed Al Ogaili James W Choi Paul Poommipanit Khaldoon Alaswad Mir Babar Basir Rhian Davies Farouc A Jaffer Phil Dattilo Lorenzo Azzalini Nazif Aygul Niranjan Reddy Brian K Jefferson Sevket Gorgulu Jaik Source Type: research
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
CONCLUSION: In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.PMID:38686684 | DOI:10.14503/THIJ-23-8271 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - April 30, 2024 Category: Cardiology Authors: HyeYon Yu Jihun Ahn Byoung Geol Choi Soohyung Park Dong Oh Kang Cheol Ung Choi Seung-Woon Rha Myung Ho Jeong Source Type: research
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
CONCLUSION: In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.PMID:38686684 | DOI:10.14503/THIJ-23-8271 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - April 30, 2024 Category: Cardiology Authors: HyeYon Yu Jihun Ahn Byoung Geol Choi Soohyung Park Dong Oh Kang Cheol Ung Choi Seung-Woon Rha Myung Ho Jeong Source Type: research
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
CONCLUSION: In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.PMID:38686684 | DOI:10.14503/THIJ-23-8271 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - April 30, 2024 Category: Cardiology Authors: HyeYon Yu Jihun Ahn Byoung Geol Choi Soohyung Park Dong Oh Kang Cheol Ung Choi Seung-Woon Rha Myung Ho Jeong Source Type: research
